IGIV
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IGIV, covering 2015-03-31 to 2021-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously [Phase 1, Phase 2]